December 12, 2024 20:59 (IST)
COVID-19: Pfizer vaccine shows 100 percent efficiency in adolescents after 4 months
Nov 24, 2021, at 03:03 pm
New York: Pfizer Inc.and BioNTech SE have announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals aged between 12 through 15 years, where it was found that two-dose series showed 100 percent efficiency against the virus after four months.
Pfizer's COVID vaccine approved for minors aged 12-15 in Japan
Jun 01, 2021, at 01:49 pm
Moscow/Sputnik: The Japanese government approved Pfizer's COVID-19 vaccine for ages 12 to 15 on Monday, the media reported.
Latest Headlines